HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

3rd Edition of Cardiology World Conference

September 14-15, 2022 | Hybrid Event

September 14 -15, 2022 | Paris, France
CWC 2021

: Chagas cardiomyopathy - what every cardiologist needs to know

Fernanda de Souza Nogueira Sardinha Mendes, Speaker at Speaker for CWC Conference- Fernanda de Souza Nogueira Sardinha Mendes
Oswaldo Cruz Foundation, Brazil
Title : : Chagas cardiomyopathy - what every cardiologist needs to know


Chagas disease (CD) is classified as a neglected tropical disease caused by the protozoan Trypanosoma cruzi. It affects around 6 to 8 million people worldwide, especially in Latin America but also in United States and Europe. Thirty percent of all CD patients progress to the most serious manifestation of CD, the Chagas Heart disease (CHD) with a high morbidity and mortality rates and a great impact for health and social systems. CHD is classified into four stages of increasing severity according to electrocardiographic, echocardiographic, and clinical criteria. Stage A – abnormal electrocardiogram and normal echocardiogram findings; Stage B1 - abnormal electrocardiogram and echocardiogram findings with a left ventricular ejection fraction (LVEF) > 45%; Stage B2 - abnormal electrocardiogram and echocardiogram findings with LVEF < 45% and no HF symptoms; Stage C - compensated HF; and stage D - refractory HF. The main clinical manifestations of CHD are cardiac arrhythmias, thromboembolism, and heart failure (HF) and has a higher incidence of sudden death and stroke than heart failure caused by other etiologies. Because of this, it is important to understand the clinical manifestations, diagnosis, risk stratification and specialized approach to help clinicians and cardiologists to better care of CHD patients using diagnostic tools and pharmacological and non-pharmacological treatments.


Dr. Fernanda Sardinha is graduated in Medicine at the Federal Fluminense University. She then conclude a post- graduation in Sports and Exercise medicine, then residence in internal medicine in the Brazilian Air Force (Air Force Central Hospital) and cardiology in the Rio de Janeiro Federal University. In 2014 received a master degree in Cardiology in the same University. She then joined the research group of Chagas disease at the Evandro Chagas National Institute of Infectious Disease / Fiocruz. She received her PhD degree in 2018 at the same institution where she is associate professor. She has published more than 30 research articles in science journals.